Independent prognostic importance of microvessel density in endometrial carcinoma
- PMID: 9569052
- PMCID: PMC2150144
- DOI: 10.1038/bjc.1998.189
Independent prognostic importance of microvessel density in endometrial carcinoma
Abstract
Angiogenesis is thought to be an important factor for tumour growth and metastatic spread, and microvessel counts may provide useful prognostic information for several tumour types. To investigate the prognostic impact of angiogenesis in endometrial carcinoma patients, the intratumour microvessel density, which was determined immunohistochemically, has been related to survival. Sixty patients with endometrial carcinoma with long (median 19 years) and complete follow-up have been studied. Patients with increased mean microvessel density (MVDmean > 68 mm2) had a significantly shorter 5-year survival compared with the rest (57% vs 90%, P = 0.004). In multivariate survival analyses, MVDmean had an independent prognostic impact (P = 0.03) when FIGO stage, histological type, histological grade as well as nuclear p53 protein expression was adjusted for. These findings indicate that intratumour microvessel density may contribute additional prognostic information to that obtained from the known risk factors and may be helpful in identifying endometrial carcinoma patients at high risk for disease progression.
Similar articles
-
Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.Int J Cancer. 1999 Oct 22;84(5):538-43. doi: 10.1002/(sici)1097-0215(19991022)84:5<538::aid-ijc17>3.0.co;2-b. Int J Cancer. 1999. PMID: 10502735
-
Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.J Clin Oncol. 1999 May;17(5):1382-90. doi: 10.1200/JCO.1999.17.5.1382. J Clin Oncol. 1999. PMID: 10334522
-
Angiogenesis in endometrial carcinoma.Cancer. 1997 Aug 15;80(4):741-7. doi: 10.1002/(sici)1097-0142(19970815)80:4<741::aid-cncr13>3.0.co;2-t. Cancer. 1997. PMID: 9264358
-
[Angiogenesis-prognostic factor in patients with endometrial cancer].Ginekol Pol. 2005 Oct;76(10):838-45. Ginekol Pol. 2005. PMID: 16417101 Review. Polish.
-
Angiogenesis in malignancies of the female genital tract.Gynecol Oncol. 1999 Feb;72(2):220-31. doi: 10.1006/gyno.1998.5152. Gynecol Oncol. 1999. PMID: 10021305 Review.
Cited by
-
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.Gynecol Oncol. 2007 May;105(2):508-16. doi: 10.1016/j.ygyno.2007.01.019. Epub 2007 Feb 15. Gynecol Oncol. 2007. PMID: 17306350 Free PMC article. Clinical Trial.
-
Recent Advances in Endometrial Cancer.F1000Res. 2017 Jan 27;6:81. doi: 10.12688/f1000research.10020.1. eCollection 2017. F1000Res. 2017. PMID: 28184290 Free PMC article. Review.
-
Promising novel therapies for the treatment of endometrial cancer.Gynecol Oncol. 2010 Feb;116(2):187-94. doi: 10.1016/j.ygyno.2009.10.041. Epub 2009 Nov 10. Gynecol Oncol. 2010. PMID: 19903572 Free PMC article. Review.
-
Vasculogenic mimicry and tumor angiogenesis.Am J Pathol. 2000 Feb;156(2):361-81. doi: 10.1016/S0002-9440(10)64739-6. Am J Pathol. 2000. PMID: 10666364 Free PMC article. Review.
-
Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.Cancer Sci. 2008 May;99(5):914-9. doi: 10.1111/j.1349-7006.2008.00777.x. Epub 2008 Mar 3. Cancer Sci. 2008. PMID: 18325046 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous